Bausch Health Announces 2021 Annual Meeting of Shareholder Results

Bausch Health Companies Inc. today announced the election of the 13 directors nominated at its 2021 annual meeting of shareholders held on April 27, 2021 . The detailed results of the vote for the election of directors are set out below: At the annual meeting of shareholders, shareholders also approved in a non-binding advisory vote the compensation of the Company’s named executive officers and appointed …

– Bausch Health Companies Inc. (NYSETSX: BHC) (“Bausch Health” or the “Company”) today announced the election of the 13 directors nominated at its 2021 annual meeting of shareholders held on April 27, 2021 . The detailed results of the vote for the election of directors are set out below:

Name	For	Withheld	Broker Non-Votes
Richard U. De Schutter	200,369,606	5,768,489	60,380,196
D. Robert Hale	196,356,636	9,781,459	60,380,196
Brett Icahn	196,491,749	9,646,346	60,380,196
Dr. Argeris (Jerry) N. Karabelas	198,928,372	7,209,723	60,380,196
Sarah B. Kavanagh	203,110,562	3,027,533	60,380,196
Steven D. Miller	200,857,243	5,280,852	60,380,196
Joseph C. Papa	198,455,884	7,682,211	60,380,196
John A. Paulson	205,191,567	946,528	60,380,196
Robert N. Power	177,088,588	29,049,507	60,380,196
Russel C. Robertson	197,810,980	8,327,115	60,380,196
Thomas W. Ross, Sr.	186,746,866	19,391,229	60,380,196
Andrew C. von Eschenbach, M.D.	205,016,196	1,121,899	60,380,196
Amy B. Wechsler, M.D.	200,266,488	5,871,607	60,380,196

At the annual meeting of shareholders, shareholders also approved in a non-binding advisory vote the compensation of the Company’s named executive officers and appointed PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm until the close of the Company’s 2022 annual meeting of shareholders.

The final vote tabulation on all matters voted on at the meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K, and such report will be made available on the Company’s website at www.bauschhealth.com .

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people’s lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com .

Investor Contact:	Media Contact:
Arthur Shannon	Lainie Keller
arthur.shannon@bauschhealth.com	lainie.keller@bauschhealth.com
(514) 856-3855	(908) 927-1198
(877) 281-6642 (toll free)